Coronavirus infection. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group use Lactocar brand Synbiotic in the form of 250 capsules containing 7 probiotic strains. Two capsules are consumed every day after lunch for
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age 18-70 years old Basic literacy Writing ability and healthy memory Mental conditions for continuing to attend the study and completing the consent form
Exclusion criteria
Exclusion criteria: Simultaneous participation in other clinical trial studies Having other acute and serious diseases Regular and periodic consumption of special dietary supplements or special diets Taking other probiotic supplements Receive corticosteroids in full dose People with pancreatitis, sepsis, dialysis, central venous and chronic diarrhea People waiting for abdominal surgery People with acute immune deficiencies such as AIDS People with short bowel syndrome or are at risk for mesenteric ischemia Pregnant women and mothers who are breastfeeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammatory markers. Timepoint: Before and 8 weeks after start of intervention. Method of measurement: Biochemical analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: Comment by physician. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMajid Aghadavood Marnani
Esfahan University of Medical Sciences
Outcome results
None listed